LD 1601
pg. 4
Page 3 of 6 PUBLIC Law Chapter 430 Page 5 of 6
Download Chapter Text
LR 557
Item 1

 
3.__Immunity; presumption of good faith.__A pharmacist or person
acting at the direction of a pharmacist who in good faith and
pursuant to subsection 2 refuses to fill any prescription, dispense
any drug or sell any targeted methamphetamine precursor or who
makes a report to a law enforcement agency is immune from any civil
liability that might otherwise result from that action, including,
but not limited to, any civil liability that might otherwise arise
under state or local laws or rules regarding confidentiality of
information. In a proceeding regarding immunity from liability,
there is a rebuttable presumption of good faith.

 
4.__Record keeping.__With regard to purchases of targeted
methamphetamine precursors, a pharmacy may keep a log of
information about the purchaser, which may include name, date of
birth, address and amount of targeted methamphetamine precursors
purchased.

 
5.__Rulemaking. The Director of the Office of Substance Abuse
within the Department of Health and Human Services may adopt
rules to implement this subsection.__Rules adopted pursuant to
this subsection are major substantive rules as defined in Title
5, chapter 375, subchapter 2-A.

 
A.__If the Director of the Maine Drug Enforcement Agency
within the Department of Public Safety finds that the ease
of availability of liquid, liquid-filled capsule or glycerin
matrix forms of products containing ephedrine,
pseudoephedrine or phenylpropanolamine or their salts,
isomers or salts of isomers, either alone or in combination
with other ingredients, referred to in this paragraph as
"products," is a threat to the public health, safety and
welfare, then the Director of the Maine Drug Enforcement
Agency shall notify the Director of the Office of Substance
Abuse.__The Director of the Office of Substance Abuse shall
consult with the joint standing committee of the Legislature
having jurisdiction over health and human services matters,
providing the reasons for undertaking rulemaking, and may,
after consultation, adopt rules designating the products as
targeted methamphetamine precursors pursuant to section
13702, subsection 25-B, paragraph B.

 
B. If the Director of the Maine Drug Enforcement Agency finds
that sales of targeted methamphetamine precursors that are made
without verifying the identity of the purchaser pose a threat to
public health, safety and welfare, then the Director of the Maine
Drug Enforcement Agency shall notify the Director of the Office
of Substance Abuse.__The Director of the Office of Substance
Abuse shall consult with the


Page 3 of 6 Top of Page Page 5 of 6
Related Pages
  Search Bill Text Legislative Information
Bill Directory Search
Bill
Status
Session Information
119th Legislature Bills Maine Legislature

Office of Legislative Information
100 State House Station
Augusta, ME 04333
voice: (207) 287-1692
fax: (207) 287-1580
tty: (207) 287-6826
Word Viewer for Windows Disclaimer